[WPRTS] QoQ Annualized Quarter Result on 30-Sep-2015 [#3]

Stock
[WPRTS] WESTPORTS HOLDINGS BERHAD
Announcement Date
13-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- 2.45%
YoY- -0.02%
Quarter Report
Latest QR
Upcoming QR
WPRTS's Result
WPRTS's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 1,974,682 1,858,856 1,681,783 1,606,369 1,608,004 1,594,888 1,562,079 16.92%
PBT 805,970 843,980 650,143 645,305 643,294 638,400 578,781 24.72%
Tax -144,070 -159,668 -145,279 -148,880 -158,738 -157,656 -66,576 67.38%
NP 661,900 684,312 504,864 496,425 484,556 480,744 512,205 18.65%
-
NP to SH 661,900 684,312 504,864 496,425 484,556 480,744 512,205 18.65%
-
Tax Rate 17.88% 18.92% 22.35% 23.07% 24.68% 24.70% 11.50% -
Total Cost 1,312,782 1,174,544 1,176,919 1,109,944 1,123,448 1,114,144 1,049,874 16.08%
-
Net Worth 2,011,899 1,851,970 1,898,005 1,760,583 1,803,549 1,674,651 1,764,334 9.15%
Dividend
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Div 497,860 - 378,510 241,882 362,824 - 383,625 18.99%
Div Payout % 75.22% - 74.97% 48.72% 74.88% - 74.90% -
Equity
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Net Worth 2,011,899 1,851,970 1,898,005 1,760,583 1,803,549 1,674,651 1,764,334 9.15%
NOSH 3,410,000 3,410,000 3,410,000 3,410,000 3,410,000 3,410,000 3,410,000 0.00%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin 33.52% 36.81% 30.02% 30.90% 30.13% 30.14% 32.79% -
ROE 32.90% 36.95% 26.60% 28.20% 26.87% 28.71% 29.03% -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 57.91 54.51 49.32 47.11 47.16 46.77 45.81 16.92%
EPS 19.42 20.08 14.81 14.56 14.20 14.08 15.02 18.70%
DPS 14.60 0.00 11.10 7.09 10.64 0.00 11.25 18.99%
NAPS 0.59 0.5431 0.5566 0.5163 0.5289 0.4911 0.5174 9.15%
Adjusted Per Share Value based on latest NOSH - 3,410,000
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 57.91 54.51 49.32 47.11 47.16 46.77 45.81 16.92%
EPS 19.42 20.08 14.81 14.56 14.20 14.08 15.02 18.70%
DPS 14.60 0.00 11.10 7.09 10.64 0.00 11.25 18.99%
NAPS 0.59 0.5431 0.5566 0.5163 0.5289 0.4911 0.5174 9.15%
Price Multiplier on Financial Quarter End Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 -
Price 4.20 4.13 4.12 4.24 4.23 4.02 3.36 -
P/RPS 7.25 7.58 8.35 9.00 8.97 8.60 7.33 -0.72%
P/EPS 21.64 20.58 27.83 29.13 29.77 28.51 22.37 -2.18%
EY 4.62 4.86 3.59 3.43 3.36 3.51 4.47 2.22%
DY 3.48 0.00 2.69 1.67 2.52 0.00 3.35 2.57%
P/NAPS 7.12 7.60 7.40 8.21 8.00 8.19 6.49 6.37%
Price Multiplier on Announcement Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 28/07/16 28/04/16 03/02/16 13/11/15 31/07/15 30/04/15 11/02/15 -
Price 4.39 4.20 3.95 4.32 4.01 4.50 3.50 -
P/RPS 7.58 7.70 8.01 9.17 8.50 9.62 7.64 -0.52%
P/EPS 22.62 20.93 26.68 29.67 28.22 31.92 23.30 -1.95%
EY 4.42 4.78 3.75 3.37 3.54 3.13 4.29 2.01%
DY 3.33 0.00 2.81 1.64 2.65 0.00 3.21 2.47%
P/NAPS 7.44 7.73 7.10 8.37 7.58 9.16 6.76 6.60%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment